Curium, a world leader in nuclear medicine, announced today that it has expanded its existing partnership with Institute of ...

Curium, a world leader in nuclear medicine, today announced that in Estonia, Finland, Latvia, and Sweden, PYLCLARI® is now ...

Curium introduces innovative 18F-PSMA PET radiopharmaceutical, Pylclari to treat prostate cancer in Estonia, Finland, Latvia, & Sweden: Paris, France Wednesday, January 29, 2025, ...

Portsmouth’s leading workspace, has announced a new lettings agreement with Curium - the world-leading nuclear medicine ...

The whiskey is named Curium, and the brand claimed most of the bottles sold out in the tasting room. Barrels of Curium were held back and moved to a rack to age for an additional three to four years.

Telix, a commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals, announces that it has entered ...

That in itself makes it extremely cool. Curium, named after the double Nobel laureate Marie Curie and her husband Pierre, was discovered in 1944 by a scientist called Glenn Seabourg (along with ...

MELBOURNE, Australia and LIÈGE, Belgium, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has entered into an agreement ...

PARIS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, today announced that in Estonia, Finland, Latvia, and Sweden, PYLCLARI® is now available for patients with ...

Scintimun is an internationally approved product [2] and has previously been manufactured and distributed by Curium Pharma through an out-license from Telix via the acquisition of TheraPharm in 2020 ...